Table 3.
Step 1 | Step 2 | Step 3 | Step 4 | Step 5 | Step 6 | |
---|---|---|---|---|---|---|
Preferred: SABA as needed | For 6–8 weeks Preferred: Low-dose ICS Alternative: LTRA | Preferred: Low-dose ICS + LABA or medium-dose ICS Alternative: Low-dose ICS + LTRA | Preferred: Medium-dose ICS + LABA Alternative: Medium-dose-ICS + LTRA | Preferred: High-dose ICS + LABA and LTRA. Consider omalizumab for patients with allergies | Preferred: High-dose ICS + LABA and LTRA. Consider tiotropium and omalizumab for patients with allergies | Step up when needed (first check adherence, inhaler technique, and environmental control) Assess control: Step down if possible when asthma is well-controlled for at least 3 months |
Abbreviations: ICS, inhaled corticosteroids; LABA, long-acting β2-agonists; LTRA, leukotriene receptor agonists; SABA, short-acting β2-agonists.